← Scroll for more →
Oramed Pharmaceuticals Inc. (ORMP)
Pharmaceutical Preparations
Latest Price
$4.08
TTM P/E
0.99
Normalized P/E
3.79
TTM Div Yield
--
Fwd Div Yield
--
Book Value
7.76
P/B Ratio
0.53
Valuation metrics
adjust assumptions →EPS: $1.50
Book value / share: $5.09
Formula: √(22.5 × EPS × BVPS)
Graham Number
$13.10
+221% upside
EPS: $1.50
Target P/E: 4×
Formula: EPS × P/E
P/E Fair Value
$6.00
+47% upside
Institutional Ownership
35.6% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Aquamarine Financial (Cayman) Ltd | 2.51M | $12.0M | 6.08% | +399.9K | 2026-06-30 |
| Gem Investment Advisors, LLC | 2.00M | $9.0M | 4.84% | +358.7K | 2026-06-30 |
| Mercer Global Advisors Inc | 1.91M | $9.0M | 4.62% | -- | 2026-06-30 |
| BlackRock, Inc. | 1.61M | $7.0M | 3.89% | +1.52M | 2026-06-30 |
| Murchinson Ltd. | 1.29M | $6.0M | 3.12% | -25.0K | 2026-06-30 |
| BML Capital Management, LLC | 866.3K | $4.0M | 2.10% | -2.30M | 2026-06-30 |
| Boothbay Fund Management, LLC | 578.6K | $2.0M | 1.40% | -22.1K | 2026-06-30 |
| Geode Capital Management, LLC | 500.7K | $2.0M | 1.21% | +476.4K | 2026-06-30 |
| Goldman Sachs Group Inc | 253.3K | $1.0M | 0.61% | -- | 2026-06-30 |
| State Street Corp | 242.1K | $1.0M | 0.59% | +175.6K | 2026-06-30 |